New report calls for increase in government aid for countermeasures

Friday, Aug 20, 2010 @ 3:49pm by BioPrepWatch Reports

A newly released U.S. Department of Health and Human Services report outlines several areas where medical countermeasures for bioterror are lacking and recommends new approaches.
Read More »

TASC, Inc. names new director of Chemical-Biological Defense Programs

Monday, Aug 9, 2010 @ 1:44pm by BioPrepWatch Reports

TASC, Inc., has appointed Dr. Rashid Chotani as director of Chemical-Biological Defense Programs.
Read More »

Federal officials okay emergency transport plans for infected workers

Friday, Jul 30, 2010 @ 3:14pm by BioPrepWatch Reports

Federal officials from the National Institutes of Health have given the green light to emergency plans to transport laboratory workers potentially infected with some of the world
Read More »

HHS seeks comments on its select agents and toxins list

Tuesday, Jul 27, 2010 @ 3:34pm by BioPrepWatch Reports

The U.S. Department of Health and Human Services recently called for comments on its list of select agents and toxins.
Read More »

Smallpox vaccine delivered to national stockpile

Wednesday, Jul 14, 2010 @ 9:28pm by BioPrepWatch Reports

One million doses of the smallpox vaccine IMVAMUNE have been delivered to the U.S. Strategic National Stockpile for use in the event of a smallpox bioterrorism attack on the U.S.
Read More »

University professor barred from lab over unauthorized bioterror agent expirements

Tuesday, May 18, 2010 @ 9:50pm by BioPrepWatch Reports

Laboratory privileges for a University of Wisconsin - Madison professor have been suspended for five years after he was found to have conduct unauthorized experiments with potential bioterror agents.
Read More »

Emergent BioSolutions, Inc.'s IND for anthrax antibody clears FDA review

Tuesday, May 18, 2010 @ 8:00pm by BioPrepWatch Reports

Officials with Emergent BioSolutions, Inc., announced on Monday that the company's Investigational New Drug application to begin clinical trials for an anthrax antibody has cleared review by the U.S. Food and Drug Administration.
Read More »

New finding about anthrax proteins could aid in fighting the biothreat

Friday, May 7, 2010 @ 7:26pm by BioPrepWatch Reports

A team of New York University microbiologists have discovered that bacterial spores carry an extra coating of protection that has been previously undetected by researchers, opening the door for new anthrax eradication techniques.
Read More »

Experts question preparation of EMS in bioterror event

Friday, Mar 26, 2010 @ 2:33pm by BioPrepWatch Reports

Terrorism's recent "Prevention of WMD Proliferation and Terrorism Report Card" raised the specter of the U.S.'s lack of preparation to protect its people and frontline responders in the face of a bioterror attack.
Read More »

NIH releases 2011 budget

Monday, Mar 15, 2010 @ 3:33pm by Nick Rees

The National Institutes of Health spent more than half of the $8.2 billion it received for science under the American Recovery and Reinvestment Act of 2009 last year, or $4.6 billion, and expects to spend another $3.6 billion this yea
Read More »

Ties to Democratic Party by PharmAthene questioned

Friday, Feb 26, 2010 @ 6:03pm by Nick Rees

Fox News has reported on the Obama administration's steering of as much as $150 million in federal funding for an anthrax vaccine to a biodefense firm that holds strong Democratic Party ties.
Read More »

Effort extended in fight against Lassa virus

Tuesday, Feb 9, 2010 @ 6:54pm by Nick Rees

A major extension in the collaborative effort between Corgenix Medical Corporation and Tulane University has been announced to combat viral hemorrhagic fever.
Read More »

University of Florida dedicates new headquarters for Emerging Pathogens Institute

Wednesday, Jan 27, 2010 @ 3:34pm by BioPrepWatch Reports

The University of Florida has held a ribbon cutting ceremony for its new, 80,000-square-foot Emerging Pathogens Institute.
Read More »

Report finds OSU president acted within his authority in ending anthrax study

Thursday, Jan 21, 2010 @ 4:17pm by Nick Rees

An Oklahoma State University faculty report has declared that university president Burns Hargis was acting within his authority when he stopped a research project on anthrax vaccines that would have euthanized baboons.
Read More »

Biodefense industry leaders meet to discuss changes to BioShield

Thursday, Jan 14, 2010 @ 2:54pm by BioPrepWatch Reports

Biodefense industry leaders have met to discuss how to facilitate the development and approval of products in the biodefense sector following the decision to remove funds from the BioShield Special Reserve Fund.
Read More »

Grant awarded to develop quicker methods of diagnosing bioagents

Wednesday, Jan 13, 2010 @ 3:25pm by BioPrepWatch Reports

The National Institutes of Health have awarded a grant to develop quick diagnostic methods for bacterial agents requiring limited resources and personnel.
Read More »

- NIH grants to aid study of smallpox

Tuesday, Jan 5, 2010 @ 3:59pm by BioPrepWatch Reports

New grants from the U.S. National Institutes of Health will aid in immunological research on several diseases, including smallpox, which could be used by bioterrorists.
Read More »

Study published by Soligenix on characteristics of ricin A chain

Tuesday, Dec 29, 2009 @ 3:22pm by Nick Rees

Soligenix, Inc., has announced the publication of an article that details the characteristics of several immunodominant regions of ricin A chain - the antigenic component of Rivax - in the January 2010 edition of Infection and Immunity.
Read More »

Contract awarded for inhalation anthrax medication

Thursday, Dec 24, 2009 @ 4:12pm by Nick Rees

The Biomedical Advanced Research and Development AUthority has awarded Pine Brook, N.J.-based Elusys Therapeutics, Inc., a contract for the advanced development of a medication to treat inhalational anthrax.
Read More »

La Jolla Institute receives funding to study smallpox threat

Friday, Dec 18, 2009 @ 3:18pm by Nick Rees

A federally funded, five year, $18.8 million set of projects by researchers at the La Jolla Institute for Allergy & Immunology aims to make inroads on defeating several diseases identified as bioterror threats.
Read More »